Skip to main content
. 2017 Aug 4;36(1):51–60. doi: 10.1007/s11419-017-0378-5

Table 1.

Activities of enantiomers of each compound at human CB1 and CB2 receptors

Compound name Human CB1 receptor Human CB2 receptor Selective indexb (CB1/CB2)
EC50 (M) S/R ratioa EC50 (M) S/R ratioa
(S)AB-FUBINACA 2-fluorobenzyl isomer 2.92 × 10−9 0.21 2.44 × 10−9 3.9 1.20
(R)AB-FUBINACA 2-fluorobenzyl isomer 1.41 × 10−8 6.27 × 10−10 22.5
(S)APP-CHMINACA 2.51 × 10−7 0.0074 8.09 × 10−9 0.017 31.0
(R)APP-CHMINACA 3.37 × 10−5 4.90 × 10−7 68.8
(S)EMB-FUBINACA 4.58 × 10−10 0.015 2.14 × 10−9 2.5 0.214
(R)EMB-FUBINACA 3.07 × 10−8 8.63 × 10−10 35.6
(S)5F-EMB-PINACA 4.96 × 10−9 0.14 6.91 × 10−9 4.1 0.718
(R)5F-EMB-PINACA 3.59 × 10−8 1.68 × 10−9 21.4
(S)MDMB-FUBICA 9.72 × 10−9 <0.0001 1.07 × 10−9 0.35 9.08
(R)MDMB-FUBICA >1.00 × 10−4 3.10 × 10−9 >30,000
CP55940 1.28 × 10−9 1.54 × 10−10 8.3

a S/R ratio is the EC50 value ratio of an (S)-enantiomer to the corresponding (R)-enantiomer

bSelective index is EC50 ratio of the CB1 to CB2